Christine E. Thomas - 10 Oct 2022 Form 4 Insider Report for FEMASYS INC (FEMY)

Role
SVP, Regulatory & Clinical
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
Issuer symbol
FEMY
Transactions as of
10 Oct 2022
Net transactions value
$0
Form type
4
Filing time
17 Oct 2022, 16:48:38 UTC
Next filing
01 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FEMY Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 10 Oct 2022 Common Stock 50,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2023, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.